Publication | Closed Access
Pooled resistance analysis in HCV genotype 1–6-infected patients treated with glecaprevir/pibrentasvir in phase 2 and 3 clinical trials
32
Citations
0
References
2017
Year
Viral DiagnosticsViral HepatitisClinical TrialsHepatitisVirologyAntiviral TherapyInfection ControlPhase 2MedicineClinical MicrobiologyEpidemiologyResistance AnalysisHealth Sciences
No additional data available for this publication yet. Check back later!